Jackson Square Partners’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-230,997
Closed -$30.4M 61
2024
Q4
$30.4M Sell
230,997
-687,062
-75% -$3.13M 3.17% 6
2024
Q3
$5.78M Sell
918,059
-506,933
-36% -$3.41M 0.5% 45
2024
Q2
$9.5M Sell
1,424,992
-184,930
-11% -$1.09M 0.58% 43
2024
Q1
$8.5M Sell
1,609,922
-19,824
-1% -$93.2K 0.35% 51
2023
Q4
$8.41M Buy
1,629,746
+174,737
+12% +$539K 0.27% 50
2023
Q3
$4.9M Sell
1,455,009
-261,195
-15% -$1.72M 0.16% 57
2023
Q2
$14.2M Buy
1,716,204
+437,143
+34% +$3.94M 0.41% 34
2023
Q1
$11.2M Buy
1,279,061
+69,357
+6% +$770K 0.3% 44
2022
Q4
$14.8M Buy
1,209,704
+366,093
+43% +$3.48M 0.39% 43
2022
Q3
$5.36M Buy
843,611
+248,560
+42% +$2.1M 0.14% 59
2022
Q2
$5.35M Buy
595,051
+130,770
+28% +$1.15M 0.12% 56
2022
Q1
$5.37M Sell
464,281
-131,443
-22% -$2.02M 0.05% 78
2021
Q4
$10.5M Buy
595,724
+255,405
+75% +$5.6M 0.09% 73
2021
Q3
$7.72M Buy
+340,319
New +$11.2M 0.05% 78

Other funds holding SGHT

Jackson Square Partners's SGHT Position: Q1 2025 in Review

Jackson Square Partners sold out of Sight Sciences (SGHT) in Q1 2025, closing a stake of 230,997 shares — an estimated $30.4M sold.

Jackson Square Partners first reported a position in SGHT in Q3 2021 and held it in 14 quarters. The position peaked at $30.4M in Q4 2024. 77 funds tracked by Wall St. Rank hold SGHT as of Q1 2025.

  • Jackson Square Partners reported no remaining Sight Sciences position as of Q1 2025 after selling out during the quarter.
  • Jackson Square Partners sold 230,997 Sight Sciences shares in Q1 2025, an estimated $30.4M.
  • Jackson Square Partners first reported a position in Sight Sciences in Q3 2021 and held it in 14 quarters.
  • Jackson Square Partners's Sight Sciences position peaked at $30.4M in Q4 2024.
  • 77 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2025.

Based on Jackson Square Partners's 13F filing for Q1 2025, filed 12 May 2025.